Mismatch negativity and P3a in patients with Schizophrenia
DOI:
https://doi.org/10.21615/cesp.5690Keywords:
event related potentials, electroencephalography, amplitude, biomarker, schizophrenia, preattentional auditory processing, central auditory processing, Mismatch negativity, P3aAbstract
Background: schizophrenia is a chronic disease that generates great disability, which currently has potential biomarkers but without sufficient clinical validity. Mismatch negativity (MMN) and P3a are event-related potentials that have been shown to be neurophysiological indicators of pre-attentional auditory processing and potential biomarkers. Objective: to evaluate MMN and P3a in patients with a diagnosis of schizophrenia and their relationship with sociodemographic and clinical variables. Method: a quantitative cross-sectional study of 23 subjects with schizophrenia and 22 healthy controls was performed. The average amplitudes and latencies of the MMN/P3a for the condition infrequent in duration and infrequent in frequency were obtained using an auditory oddball paradigm on a 32-channel EEG. Results: differences were found for the frequency condition in the amplitude of the MMN (p=0.046; 95% CI 0.009; 0.87) and the amplitude of the P3a (p=0.042; 95% CI 0.025; 1.24) between the groups; MMN amplitude was lower in schizophrenia (-0.36 SD 0.51 µV) compared to healthy controls (-0.81 SD 0.89 µV), while P3a amplitude was lower in healthy controls (0.18 SD 0.97 µV) versus the group with schizophrenia (0.82 SD 1.05 µV). In regard to sociodemographic and clinical variables, the associations with P3a were moderate, and showed weak MMN. Conclusions: MMN amplitude reduction to the frequency condition exhibits greater utility than P3a as a measure of high stability in schizophrenia, restating its potential use as a biomarker.
Downloads
References
American Psychiatric Association (Ed.). (2014). Guía de consulta de los criterios diagnósticos del DSM-5. American Psychiatric Publishing.
Atkinson, R. J., Michie, P. T., & Schall, U. (2012). Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biological Psychiatry, 71(2), 98-104. https://doi.org/10.1016/j.biopsych.2011.08.023
Belger, A., Yucel, G. H., & Donkers, F. C. L. (2012). In search of psychosis biomarkers in high-risk populations: Is the mismatch negativity the one we’ve been waiting for? Biological Psychiatry, 71(2), 94-95. https://doi.org/10.1016/j.biopsych.2011.11.009
Bodatsch, M., Ruhrmann, S., Wagner, M., Müller, R., Schultze-Lutter, F., Frommann, I., … Brockhaus-Dumke, A. (2011). Prediction of Psychosis by Mismatch Negativity. Biological Psychiatry, 69(10), 959-966. https://doi.org/10.1016/j.biopsych.2010.09.057
Butler, P. D., Chen, Y., Ford, J. M., Geyer, M. A., Silverstein, S. M., & Green, M. F. (2012). Perceptual measurement in schizophrenia: Promising electrophysiology and neuroimaging paradigms from CNTRICS. Schizophrenia Bulletin, 38(1), 81-91. https://doi.org/10.1093/schbul/sbr106
Corcoran, C. M., Keilp, J. G., Kayser, J., Klim, C., Butler, P. D., Bruder, … Javitt, D. C. (2015). Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: A neurodevelopmental perspective. Psychological Medicine, 45(14), 2959-2973. https://doi.org/10.1017/S0033291715000902
Duncan, C. C., Barry, R. J., Connolly, J. F., Fischer, C., Michie, P. T., Näätänen, R., … Van Petten, C. (2009). Event-related potentials in clinical research: Guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology, 120(11), 1883-1908. https://doi.org/10.1016/j.clinph.2009.07.045
Erickson, M. A., Ruffle, A., & Gold, J. M. (2016). A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression. Biological Psychiatry, 79(12), 980-987. https://doi.org/10.1016/j.biopsych.2015.08.025
Escera, C., & Corral, M. (2007). Role of mismatch negativity and novelty-P3 in involuntary auditory attention. Journal of Psychophysiology, 21(3-4), 251-264.
Fisher, D. J., Grant, B., Smith, D. M., Borracci, G., Labelle, A., & Knott, V. J. (2011). Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified «optimal» multi-feature paradigm. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology, 81(3), 245-251. https://doi.org/10.1016/j.ijpsycho.2011.06.018
Fisher, D. J., Labelle, A., & Knott, V. J. (2012). Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness. Schizophrenia Research, 139(1-3), 237-245. https://doi.org/10.1016/j.schres.2012.06.004
García, J., Palacio, C., Garcés, I., Arbeláez, M., Sánchez, R., & López, C. (2003). Inferencias fenomenológicas y nosológicas en la esquizofrenia a partir de la validación de las escalas de síntomas positivos (SAPS) y de síntomas negativos (SANS) en Colombia. Revista de Neuro-Psiquiatría, 66, 195-214.
Gil, L., Tamayo-Orrego, L., Ramirez-Rozo, J. D., Guerrero, C., Toro, S., & Duque-Parra, J. E. (2009). Caracterización de la onda P300 en pacientes colombianos con diagnóstico de esquizofrenia. Revista Colombiana de Psiquiatría, 38(3), 433-445.
Groppe, D. M., Urbach, T. P., & Kutas, M. (2011). Mass univariate analysis of event-related brain potentials/fields I: A critical tutorial review. Psychophysiology, 48(12), 1711-1725. https://doi.org/10.1111/j.1469-8986.2011.01273.x
Gutiérrez Giraldo, N., Rangel Galvis, C. E., Tovar, C., & Rafael, J. (2013). Medición del potencial evocado cognitivo, P300, en un grupo de individuos colombianos sanos. Revista Ciencias de la Salud, 11(2), 195-204.
Haigh, S. M., Coffman, B. A., & Salisbury, D. F. (2017). Mismatch Negativity in First-Episode Schizophrenia: A Meta-Analysis. Clinical EEG and Neuroscience, 48(1), 3-10. https://doi.org/10.1177/1550059416645980
Hay, R. A., Roach, B. J., Srihari, V. H., Woods, S. W., Ford, J. M., & Mathalon, D. H. (2015). Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. Biological Psychology, 105, 130-137. https://doi.org/10.1016/j.biopsycho.2015.01.004
Hermens, D. F., Ward, P. B., Hodge, M. A. R., Kaur, M., Naismith, S. L., & Hickie, I. B. (2010). Impaired MMN/P3a complex in first-episode psychosis: Cognitive and psychosocial associations. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(6), 822-829. https://doi.org/10.1016/j.pnpbp.2010.03.019
Higuchi, Y., Seo, T., Miyanishi, T., Kawasaki, Y., Suzuki, M., & Sumiyoshi, T. (2014). Mismatch negativity and p3a/reorienting complex in subjects with schizophrenia or at-risk mental state. Frontiers in Behavioral Neuroscience, 8, 172. https://doi.org/10.3389/fnbeh.2014.00172
Javitt, D. C., & Freedman, R. (2015). Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. The American Journal of Psychiatry, 172(1), 17-31. https://doi.org/10.1176/appi.ajp.2014.13121691
Javitt, D. C., Shelley, A. M., Silipo, G., & Lieberman, J. A. (2000). Deficits in auditory and visual context-dependent processing in schizophrenia: Defining the pattern. Archives of General Psychiatry, 57(12), 1131-1137. https://doi.org/10.1001/archpsyc.57.12.1131
Javitt, D. C., Spencer, K. M., Thaker, G. K., Winterer, G., & Hajós, M. (2008). Neurophysiological biomarkers for drug development in schizophrenia. Nature Reviews. Drug Discovery, 7(1), 68-83. https://doi.org/10.1038/nrd2463
Kathmann, N., Wagner, M., Rendtorff, N., & Engel, R. R. (1995). Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics. Biological Psychiatry, 37(10), 754-757. https://doi.org/10.1016/0006-3223(94)00309-Q
Kaur, M., Battisti, R. A., Ward, P. B., Ahmed, A., Hickie, I. B., & Hermens, D. F. (2011). MMN/P3a deficits in first episode psychosis: Comparing schizophrenia-spectrum and affective-spectrum subgroups. Schizophrenia Research, 130(1-3), 203-209. https://doi.org/10.1016/j.schres.2011.03.025
Korostenskaja, M., Dapsys, K., Maciulis, V., & Ruksenas, O. (2003). Evaluation of new MMN parameters in schizophrenia. Acta Neurobiologiae Experimentalis, 63(4), 383-388.
Light, G. A., & Braff, D. L. (2005). Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Archives of General Psychiatry, 62(2), 127-136. https://doi.org/10.1001/archpsyc.62.2.127
Light, G. A., Swerdlow, N. R., & Braff, D. L. (2007). Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. Journal of Cognitive Neuroscience, 19(10), 1624-1632. https://doi.org/10.1162/jocn.2007.19.10.1624
Light, G. A., Swerdlow, N. R., Rissling, A. J., Radant, A., Sugar, C. A., Sprock, J., … Braff, D. L. (2012). Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PloS One, 7(7), e39434. https://doi.org/10.1371/journal.pone.0039434
Light, G. A., Swerdlow, N. R., Thomas, M. L., Calkins, M. E., Green, M. F., Greenwood, T. A., … Turetsky, B. I. (2015). Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: Characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophrenia Research, 163(1-3), 63-72. https://doi.org/10.1016/j.schres.2014.09.042
Light, G. A., Williams, L. E., Minow, F., Sprock, J., Rissling, A., … Braff, D. L. (2010). Electroencephalography (EEG) and Event-Related Potentials (ERPs) with Human Participants. En J. N. Crawley, C. R. Gerfen, M. A. Rogawski, D. R. Sibley, P. Skolnick, & S. Wray (Eds.), Current Protocols in Neuroscience. John Wiley & Sons, Inc. https://doi.org/10.1002/0471142301.ns0625s52
Lin, Y.-T., Liu, C.-M., Chiu, M.-J., Liu, C.-C., Chien, Y.-L., Hwang, T.-J., … Hwu, H.-G. (2012). Differentiation of Schizophrenia Patients from Healthy Subjects by Mismatch Negativity and Neuropsychological Tests. PloS One, 7(4), e34454. https://doi.org/10.1371/journal.pone.0034454
Lopez-Calderon, J., & Luck, S. J. (2014). ERPLAB: An open-source toolbox for the analysis of event-related potentials. Frontiers in Human Neuroscience, 8, 213. https://doi.org/10.3389/fnhum.2014.00213
Mathalon, D. H., & Ford, J. M. (2012). Neurobiology of schizophrenia: Search for the elusive correlation with symptoms. Frontiers in Human Neuroscience, 6, 136. https://doi.org/10.3389/fnhum.2012.00136
Ministerio de Salud de Colombia. (1993). Resolución Nº 008430. Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud (p. 1- 12). Bogotá: Ministerio de Salud de Colombia. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.PDF
Näätänen, R., & Kähkönen, S. (2009). Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: A review. The International Journal of Neuropsychopharmacology, 12(1), 125-135. https://doi.org/10.1017/S1461145708009322
Nagai, T., Tada, M., Kirihara, K., Yahata, N., Hashimoto, R., Araki, T., & Kasai, K. (2013). Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis. Schizophrenia Research, 150(2-3), 547-554. https://doi.org/10.1016/j.schres.2013.08.005
Oades, R. D., Wild-Wall, N., Juran, S. A., Sachsse, J., Oknina, L. B., & Röpcke, B. (2006). Auditory change detection in schizophrenia: Sources of activity, related neuropsychological function and symptoms in patients with a first episode in adolescence, and patients 14 years after an adolescent illness-onset. BMC Psychiatry, 6, 7. https://doi.org/10.1186/1471-244X-6-7
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016). Schizophrenia. The Lancet, 388(10039), 86-97. https://doi.org/10.1016/S0140-6736(15)01121-6
Owens, E. M., Bachman, P., Glahn, D. C., & Bearden, C. E. (2016). Electrophysiological Endophenotypes for Schizophrenia. Harvard Review of Psychiatry, 24(2), 129-147. https://doi.org/10.1097/HRP.0000000000000110
Palacio, C. A., García, J., Arbeláez, M. P., Sánchez, R., Aguirre, B., Garcés, I. C., … Ospina, J. (2004). Validation of the Diagnostic Interview for Genetic Studies (DIGS) in Colombia. Biomédica: Revista Del Instituto Nacional De Salud, 24(1), 56-62.
Polich, J. (2007). Updating P300: An integrative theory of P3a and P3b. Clinical Neurophysiology. Official Journal of the International Federation of Clinical Neurophysiology, 118(10), 2128-2148. https://doi.org/10.1016/j.clinph.2007.04.019
Rissling, A. J., Braff, D. L., Swerdlow, N. R., Hellemann, G., Rassovsky, Y., Sprock, J., … Light, G. A. (2012). Disentangling early sensory information processing deficits in schizophrenia. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology, 123(10), 1942-1949. https://doi.org/10.1016/j.clinph.2012.02.079
Salisbury, D. F., Kuroki, N., Kasai, K., Shenton, M. E., & McCarley, R. W. (2007). Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Archives of General Psychiatry, 64(5), 521-529. https://doi.org/10.1001/archpsyc.64.5.521
Schall, U., Catts, S. V., Karayanidis, F., & Ward, P. B. (1999). Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: Valid outcome prediction of clozapine therapy in a three-year follow-up. The International Journal of Neuropsychopharmacology, 2(2), 83-93. https://doi.org/10.1017/S1461145799001418
Shelley, A. M., Ward, P. B., Catts, S. V., Michie, P. T., Andrews, S., & McConaghy, N. (1991). Mismatch negativity: An index of a preattentive processing deficit in schizophrenia. Biological Psychiatry, 30(10), 1059-1062. https://doi.org/10.1016/0006-3223(91)90126-7
Turetsky, B. I., Bilker, W. B., Siegel, S. J., Kohler, C. G., & Gur, R. E. (2009). Profile of auditory information-processing deficits in schizophrenia. Psychiatry Research, 165(1-2), 27-37. https://doi.org/10.1016/j.psychres.2008.04.013
Umbricht, D., Javitt, D., Novak, G., Bates, J., Pollack, S., Lieberman, J., & Kane, J. (1998). Effects of clozapine on auditory event-related potentials in schizophrenia. Biological Psychiatry, 44(8), 716-725. https://doi.org/10.1016/s0006-3223(97)00524-6
Umbricht, D., Javitt, D., Novak, G., Bates, J., Pollack, S., Lieberman, J., & Kane, J. (1999). Effects of risperidone on auditory event-related potentials in schizophrenia. The International Journal of Neuropsychopharmacology, 2(4), 299-304. https://doi.org/10.1017/S1461145799001595
Umbricht, D., & Krljes, S. (2005). Mismatch negativity in schizophrenia: A meta-analysis. Schizophrenia Research, 76(1), 1-23. https://doi.org/10.1016/j.schres.2004.12.002
Wechsler, D., Meng, Y., Martínez, I., & Zhu, J. (2014). WAIS-IV: Escala Wechsler de Inteligencia para Adultos-IV. Manual Moderno.
Woods, S. W. (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. The Journal of Clinical Psychiatry, 64(6), 663-667.
Zamora, R. C., Von Seggern, B., Toledo, R., & Harrell, E. H. (1990). El inventario de Edimburgo: Evaluación de la lateralidad cerebral en una población mexicana. Salud mental, 13(2), 11-17.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 CES Psicología

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Each manuscript is accompanied by a statement specifyingThat the materials are unpublished, that have not been previously published in printed formatElectronic and that they will not be presented to any other means before knowing the decision of the magazine. ThroughoutIn case, any previous publication, sea in printed or electronic form, must be made known to the editorial staffWriting The authors attach a signed statement stating that, and the manuscript is acceptedFor publication, the rights of reproduction are the exclusive property of the Journal CES Psychology.Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |